Company Information

CIN
Status
Date of Incorporation
22 August 1995
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
12 November 2022
Paid Up Capital
15,324,000
Authorised Capital
20,000,000

Directors

Ashok Kirtilal Jhaveri
Ashok Kirtilal Jhaveri
Director/Designated Partner
over 6 years ago
Shailesh Jethmal Sanghvi
Shailesh Jethmal Sanghvi
Director/Designated Partner
over 11 years ago

Past Directors

Kunal Ashok Jhaveri
Kunal Ashok Jhaveri
Additional Director
almost 7 years ago
Hasmukh Purushottam Gandhi
Hasmukh Purushottam Gandhi
Director
over 25 years ago

Patents

Novel Process For The Preparation Of Suvorexant And Intermediates Thereof

The present invention relates to a novel process for preparation of Suvorexant. The present invention also provides novel intermediates that may be used for the preparation of Suvorexant.

Process For The Preparation Of Selexipag And Intermediates Thereof

The present invention relates to a novel process for the preparation of Selexipag and its intermediates and also relates to an improved process for the preparation of Selexipag compound of formula (I).

A Method For The Preparation Of Cinacalcet

A new method for the preparation of Cinacalcet by treating (R)-1-naphthyl ethylamine with an aromatic aldehyde to form (1R)-1-(2-naphthyl)-N-(aryl methylene)ethanamine derivative which is further treated with 1 -(3-halopropyl)-3-(trifluoromethyl)benzene of formula (V) to obtain an iminiunm salt and followed by hydro...

A Method For The Preparation Of Solifenacin

A new method for the preparation of solifenacin by reacting quinuclidin-3-ol and bis (p-nitro phenyl) carbonate to form (3/0-l-azabicycIo["2.2.2]oct-3-yl 4-nitrophenyl carbonate of formula (IV); and treating (3/?)-l-azabicyclo[2.2.2]oct-3-yl 4-nitrophenyl carbonate of formula (IV) with (hS")-l-phenyl-1, 2, 3. 4-tetr...

Process For Preparation Of 4 Isopropylamino Butan 1 Ol

The present invention describes novel processes for preparation of 4-isopropylamino-butan-1-ol, a Selexipag precursor of formula (1).

Registered Trademarks

Megafine Megafine Pharma P

[Class : 5] Medicinal And Pharmaceutical Preparation For Central Nervous System

Charges

133 Crore
26 April 2012
Hdfc Bank Limited
26 Crore
13 June 2006
State Bank Of India
62 Crore
21 February 2002
Canara Bank
32 Lak
05 June 2002
Canara Bank
8 Lak
16 March 2001
Canara Bank
50 Lak
31 October 2000
Canara Bank
32 Lak
05 January 2001
Canara Bank
33 Lak
29 September 2003
Canara Bank
2 Crore
22 November 2019
Hdfc Bank Limited
44 Crore
13 June 2006
State Bank Of India
0
22 November 2019
Hdfc Bank Limited
0
26 April 2012
Hdfc Bank Limited
0
31 October 2000
Canara Bank
0
05 January 2001
Canara Bank
0
16 March 2001
Canara Bank
0
21 February 2002
Canara Bank
0
05 June 2002
Canara Bank
0
29 September 2003
Canara Bank
0
13 June 2006
State Bank Of India
0
22 November 2019
Hdfc Bank Limited
0
26 April 2012
Hdfc Bank Limited
0
31 October 2000
Canara Bank
0
05 January 2001
Canara Bank
0
16 March 2001
Canara Bank
0
21 February 2002
Canara Bank
0
05 June 2002
Canara Bank
0
29 September 2003
Canara Bank
0

Documents

Form DPT-3-21102020-signed
Form DPT-3-17042020-signed
Copy of MGT-8-16122019
List of share holders, debenture holders;-16122019
Form MGT-7-16122019_signed
Instrument(s) of creation or modification of charge;-12122019
Form CHG-1-12122019_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20191212
Instrument(s) of creation or modification of charge;-04122019
Form CHG-1-04122019_signed
CERTIFICATE OF REGISTRATION OF CHARGE-20191204
Form MSME FORM I-17112019_signed
Form AOC-4(XBRL)-15112019-signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-24102019
XBRL document in respect Consolidated financial statement-24102019
Form DIR-12-07102019_signed
Form BEN - 2-29072019_signed
Optional Attachment-(1)-29072019
Optional Attachment-(2)-29072019
Declaration under section 90-29072019
Form DPT-3-24062019
Form MSME FORM I-20062019_signed
Form MSME FORM I-08062019_signed
Declaration of the appointee director, Managing director, in Form No. DIR-2;-24122018
Evidence of cessation;-24122018
Notice of resignation;-24122018
Form DIR-12-24122018_signed
Interest in other entities;-24122018
Optional Attachment-(2)-24122018
Optional Attachment-(1)-24122018